Literature DB >> 9315470

Klebsiella pneumoniae pneumonia.

S E Prince1, K A Dominger, B A Cunha, N C Klein.   

Abstract

Klebsiella pneumoniae is an uncommon cause of community-acquired pneumonia except in alcoholics. Klebsiella may mimic pulmonary reactivation tuberculosis because it presents with hemoptysis and cavitating lesions. Klebsiella pneumoniae is a difficult infection to treat because of the organism's thick capsule. Klebsiella is best treated with third- and fourth-generation cephalosporins, quinolones, or carbapenems. Monotherapy is just as effective as a combination treatment in Klebsiella pneumoniae because newer agents are used. In the past, older agents with less anti-Klebsiella activity were needed for effective treatment. The patient we present was initially thought to have pulmonary tuberculosis, and when found to have Klebsiella pneumoniae, the suggested treatment was monotherapy with ceftriaxone. The patient was treated parenterally initially, and then was treated for 3 weeks with oral ofloxacin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315470     DOI: 10.1016/s0147-9563(97)90028-5

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  5 in total

1.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

2.  Phenol-Soluble Modulin Peptides Contribute to Influenza A Virus-Associated Staphylococcus aureus Pneumonia.

Authors:  Dominik Alexander Bloes; Emanuel Haasbach; Carmen Hartmayer; Tobias Hertlein; Karin Klingel; Dorothee Kretschmer; Oliver Planz; Andreas Peschel
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

3.  Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: clinical characteristics and treatment.

Authors:  Blandine Rammaert; Sophie Goyet; Julien Beauté; Sopheak Hem; Vantha Te; Patrich Lorn Try; Charles Mayaud; Laurence Borand; Philippe Buchy; Bertrand Guillard; Sirenda Vong
Journal:  BMC Infect Dis       Date:  2012-01-10       Impact factor: 3.090

4.  Tubercular and bacterial coinfection: A case series.

Authors:  Anshum Aneja Arora; Uma Maheswari Krishnaswamy; Riyaz P Moideen; Mantha Satya Padmaja
Journal:  Lung India       Date:  2015 Mar-Apr

5.  Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease.

Authors:  Mangesh V Suryavanshi; Shrikant S Bhute; Rahul P Gune; Yogesh S Shouche
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.